MedTrace Logo

A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers

NCT04941950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 533

Last updated 2026-04-24

Study results available
· View outcomes & findings →

Summary

The primary hypothesis of this study is that at 3 months, there will be a higher proportion of intervention participants vs. control participants who report greater risk of harm from misuse of prescription opioids AND heroin.

Conditions

  • Opioid Misuse

Interventions

BEHAVIORAL

PlaySmart

PlaySmart is designed to provide players with behavioral skills and knowledge through repetitive and engaging videogame play to target adolescent perception of risk of harm from initiating opioid misuse.

OTHER

Video Game Control

Participants in the control group will play another video game with no intended effect similar to PlaySmart.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Trustees of Dartmouth College

    lead OTHER

Principal Investigators

  • Lynn E Fiellin, MD · Director, play2PREVENT Lab & Professor, BDS at Geisel School of Medicine at Dartmouth College

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04941950 on ClinicalTrials.gov